BRIEF published on 09/29/2026 at 10:05, 1 month 5 days ago Cyprumed's Oral Delivery Technology Enters Clinical Phase with MSD Trial Clinical Development Phase I Trial Cyprumed Oral Delivery Technology MSD Collaboration
BRIEF published on 09/29/2026 at 10:05, 1 month 5 days ago La technologie d'administration orale de Cyprumed entre en phase clinique avec un essai mené par MSD. Développement Clinique Essai De Phase I Cyprumed Technologie D'administration Orale Collaboration MSD
PRESS RELEASE published on 09/29/2026 at 10:00, 1 month 5 days ago Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial Cyprumed's oral delivery technology advances to clinical stage as MSD initiates Phase I trial, marking a significant milestone in drug development Phase I Trial Clinical Stage Cyprumed MSD Oral Delivery Technology
BRIEF published on 04/15/2025 at 09:05, 1 year 6 months ago Cyprumed Partners with MSD on Oral Peptide Therapeutics Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
BRIEF published on 04/15/2025 at 09:05, 1 year 6 months ago Cyprumed s'associe à MSD pour développer des thérapies peptidiques orales Technologie D'administration De Médicaments Accord De Licence Cyprumé Partenariat MSD Thérapies Peptidiques Orales
PRESS RELEASE published on 04/15/2025 at 09:00, 1 year 6 months ago Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics Drug Delivery Technology License Agreement Cyprumed Oral Peptide Therapeutics MSD
Published on 11/04/2026 at 23:10, 6 hours 22 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 6 hours 32 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 7 hours 17 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 7 hours 27 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 04:45, 47 minutes ago Une princesse de Bourbon rejoint PinkPrincess, marque française de soins de luxe d’inspiration royale, à l’occasion de son lancement mondial
Published on 11/05/2026 at 04:45, 47 minutes ago Bourbon Princess Joins French Royal-Level Skincare Brand PinkPrincess for Global Debut
Published on 11/05/2026 at 04:15, 1 hour 17 minutes ago From Aba to Paris: Hearth Light Opens a New Chapter in International Intangible Cultural Heritage Exchange
Published on 11/05/2026 at 04:15, 1 hour 17 minutes ago D’Aba à Paris : HEARTH LIGHT ouvre un nouveau chapitre des échanges internationaux autour du patrimoine culturel immatériel
Published on 11/05/2026 at 04:00, 1 hour 32 minutes ago Andamanda Phuket: A Must-Visit Water Park for Family Holiday
Published on 11/04/2026 at 18:00, 11 hours 31 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 11 hours 31 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 11 hours 48 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
